Search

Search Results
Results 841 - 850 of 850 for Acute Lymphoblastic Leukemia
  • Health - 7 Apr 2023
    Large Granular Lymphocytic Leukemia (LGLL) is a rare cancer of one type of white blood cells, with less than 1000 new cases reported in the United States each year. These white blood cells, known as...
  • Health - 26 Jun 2019
    The hygiene hypothesis is also sometimes referred to as the biome depletion theory, or the “old friends” theory, is a hypothesis that states that the cause of allergic disease may be immune...
  • Health - 21 Mar 2019
    Large Granular Lymphocytic Leukemia (LGLL) is a rare cancer of one type of white blood cells, with less than 1000 new cases reported in the United States each year.
  • Health - 27 Feb 2019
    Raynaud’s phenomenon is a relatively rare medical condition which causes a reduction of blood circulation to the fingers or toes when exposed to cold temperatures or during stressful situations. It is...
  • Drug - 23 Apr 2024
    Consumer Medicine Information (CMI) about Iclusig intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about TE-Dasatinib intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Dasatinib-Teva intended for persons living in Australia.
  • Drug - 9 Jan 2023
    Consumer Medicine Information (CMI) about Imatinib-Teva intended for persons living in Australia.
  • Drug - 3 Aug 2022
    Consumer Medicine Information (CMI) about Glivec Tablets intended for persons living in Australia.
  • Drug - 19 Feb 2021
    Consumer Medicine Information (CMI) about Besponsa (Inotuzumab ozogamicin) intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.